L-arginine-induced hypotension

The Lancet

Volumn 336, Issue 8716, 1990, Pages 696-

  Nakaki, Toshio ^a   Hishikawa, Keiichi ^a   Suzuki, Hiromichi ^a   Saruta, Takao ^a   Kato, Ryuichi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ENDOTHELIUM DERIVED RELAXING FACTOR;

BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HYPOTENSION; LETTER; MALE; PRIORITY JOURNAL;

ADULT; AGED; ARGININE; FEMALE; HUMAN; HYPERTENSION; HYPOTENSION; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGE;

EID: 0025127426     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(90)92196-O     Document Type: Letter

References (10)

1. Effects of endothelium-derived nitric oxide on penpheral anterior tone in man
2. G-methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: does nitric oxide regulate the blood pressure in vivo?
3. Role of endothelium-derived nitric oxide in the regulation of blood pressure
4. G-methyl-L-arginine inhibits tumour necrosis factor-induced hypotension: implications for the involvement of nitric oxide
5. Identification of arginine as a precursor of endothelium-derived relaxing factor
6. Vascular endothelial cells synthesize nitric oxide from L-arginine
7. Isolation of nitric oxide synthetase, a calmodulin-requiring enyzme
8. Depletion of arterial L-arginine causes reversible tolerance to endothelium-dependent relaxation
9. Endothelial cell production of nitrogen oxides in response to interferon-gamma in combination with tumour necrosis factor, interleukin-1, or endotoxin
10. Arginine needs, physiological state and usual diets. A reevaluation